Clinical Trial Update: Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin [NA]

View source ↗

Summary

A terminated clinical trial evaluating a diabetes-focused discharge order set for poorly controlled patients transitioning to glargine U300 insulin; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glargine U300 (insulin glargine)

Snippet

Sponsor: Ohio State University | Conditions: Diabetes Mellitus, Type 2, Patient Discharge | NA | Status: TERMINATED | Results posted: 2024-02-22